CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 63 filers reported holding CIDARA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | -86.3% | 11,672 | -15.7% | 0.00% | – |
| Q2 2020 | $51,000 | +13.3% | 13,838 | +17.8% | 0.00% | – |
| Q4 2019 | $45,000 | +73.1% | 11,750 | -9.6% | 0.00% | – |
| Q3 2019 | $26,000 | -93.9% | 13,000 | -94.9% | 0.00% | -100.0% |
| Q2 2019 | $428,000 | -46.1% | 255,000 | -14.9% | 0.00% | 0.0% |
| Q1 2019 | $794,000 | +1.9% | 299,667 | -9.6% | 0.00% | 0.0% |
| Q4 2018 | $779,000 | -26.2% | 331,351 | +38.2% | 0.00% | -50.0% |
| Q3 2018 | $1,055,000 | +3.5% | 239,798 | +22.4% | 0.00% | 0.0% |
| Q2 2018 | $1,019,000 | +165.4% | 195,878 | +104.1% | 0.00% | +100.0% |
| Q1 2018 | $384,000 | +125.9% | 95,951 | +284.1% | 0.00% | – |
| Q4 2017 | $170,000 | -32.8% | 24,983 | -19.9% | 0.00% | -100.0% |
| Q3 2017 | $253,000 | +35.3% | 31,206 | +25.2% | 0.00% | – |
| Q2 2017 | $187,000 | – | 24,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |